Content about President's Emergency Plan for AIDS Relief

December 2, 2011
Mylan generic drug for HIV/AIDS receives tentative FDA approval through PEPFAR

Under the President's Emergency Plan for AIDS Relief, the Food and Drug Administration has given tentative approval to a generic HIV and AIDS drug made by Mylan, the company said.

September 20, 2011
Under PEPFAR, Matrix granted tentative approval for novel co-packaged HIV/AIDS treatment

Mylan subsidiary Matrix Labs has received tentative approval from the Food and Drug Administration for its new drug application of a co-packaged antiretroviral treatment under the President's Emergency Plan for AIDS Relief.

March 10, 2011
Under PEPFAR, Matrix Labs gets OK to sell zidovudine tablets

A subsidiary of Mylan has won approval to sell a generic drug for HIV and AIDS in developing countries under the President’s Emergency Plan for AIDS Relief.

January 20, 2011
Under PEPFAR, Matrix gets tentative approval for generic Combivir

The Food and Drug Administration has given tentative approval to an antiretroviral treatment for children with HIV and AIDS under the President’s Emergency Plan for AIDS Relief program.

December 7, 2010
Under PEPFAR, Matrix gets tentative approval for Ziagen generic

The Food and Drug Administration has given tentative approval to a generic drug for HIV/AIDS made by Mylan subsidiary Matrix Labs for distribution in developing countries under the President’s Emergency Plan for AIDS Relief, Mylan said Tuesday.

October 4, 2010
Mylan subsidiary gets approval for HIV generic under PEPFAR

The Food and Drug Administration has approved a generic drug for HIV made by a...

© 2013 Drug Store News. All Rights Reserved.